Journal of Medicinal Chemistry p. 1760 - 1764 (1986)
Update date:2022-08-04
Topics:
Iyengar, Bhashyam S.
Sami, Salah M.
Takahashi, Takeo
Sikorski, Elizabeth E.
Remers, Wiliam A.
Bradner, Wiliam T.
Twenty-three mitomycin C analogues designed to have increased metal complexing ability were synthesized and tested against P388 leukemia in mice.Their ability to complex Cu(II) was revealed by the shifts in their UV absorption spectra caused by this metal.One analogue was clearly more active than mitomycin C in the antitumor assay and two others had good activity.Correlation between antitumor activity and Cu(II) complexing ability was ambiguous.The most active compounds were either not complexers or they were complexers limited to the 2-(2-pyridyl)alkyl type substituent on N7.A variety of amino acid substituents on N7 showed only weak antitumor activity.
View MoreShanghai Yuantai Chemical Products Co., Ltd
Contact:021--66129803
Address:Chengyin Road,Shanghai,China
SHIFANG SUHONG CHEMICAL CO.,LTD
Contact:+86-838-2224563
Address:Room 1207 Zongchen Sunshine No.128 Taishan South Road,Deyang City,Sichuan China
website:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building， 132 Renmin Road
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
SHANDONG CREDAGRI CHEMICAL CO., LTD.
Contact:+86-531-88872050
Address:ROOM 601A, BUILDING 2, SHUNTAI SQUARE, NO. 2000 SHUNHUA ROAD, HI-TECH DEVELOPMENT ZONE, JINAN, CHINA.
Doi:10.1021/jo800473x
(2008)Doi:10.1002/ejoc.200701140
(2008)Doi:10.1007/BF00938577
(1952)Doi:10.1081/NCN-200040614
(2004)Doi:10.1021/jo00360a010
(1986)Doi:10.1007/s10870-013-0401-6
(2013)
